BioLife Solutions, Inc. - Common Stock — Bilan trimestriel (NASDAQ:BLFS) | MetaTrader

Afficher le graphique complet Full chart

Nouvelles

Casdin Capital et Eli Casdin cèdent 28,1 millions $ d’actions NASDAQ:BLFS

Alerte résultats : BioLife Solutions T1 2026 : le chiffre d’affaires bondit, l’action progresse

BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates

Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates

ResMed (RMD) Surpasses Q3 Earnings and Revenue Estimates

Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway

4 Medical Product Stocks to Buy From a Challenging Industry

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

Wall Street Analysts Think BioLife Solutions (BLFS) Could Surge 70.78%: Read This Before Placing a Bet

Karen A. Foster, directrice qualité et opérations, vend des actions BioLife Solutions (BLFS) pour 49.000$

After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS)

BioLife Looks Strong For Fiscal Year 2026 (NASDAQ:BLFS)